Federated Hermes’s Lifecore Biomedical LFCR Stock Holding History

Federated Hermes’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-526	Closed	-$7K	–	2016
2015 Q1	$7K	Buy	+526	New	+$7.27K	﹤0.01%	1814

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes's LFCR Position: Q2 2015 in Review

Federated Hermes sold out of Lifecore Biomedical (LFCR) in Q2 2015, closing a stake of 526 shares — an estimated $7K sold.

Federated Hermes first reported a position in LFCR in Q1 2015 and held it in 1 quarter. The position peaked at $7K in Q1 2015. 108 funds tracked by Wall St. Rank hold LFCR as of Q2 2015.

Federated Hermes reported no remaining Lifecore Biomedical position as of Q2 2015 after selling out during the quarter.
Federated Hermes sold 526 Lifecore Biomedical shares in Q2 2015, an estimated $7K.
Federated Hermes first reported a position in Lifecore Biomedical in Q1 2015 and held it in 1 quarter.
Federated Hermes's Lifecore Biomedical position peaked at $7K in Q1 2015.
108 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2015.

Based on Federated Hermes's 13F filing for Q2 2015, filed 12 Aug 2015.